Fingolimod -Response According to Coping - Evaluation

Clinical trial NCT01420055 · COMPLETED

Trial details

NCT number: NCT01420055
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2011-08-01
Primary completion: 2013-06-01
Enrollment: 189

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.